Chemoinformaics analysis of 4,5,9,10-Dehydro
| Molecular Weight | 200.325 | nRot | 0 |
| Heavy Atom Molecular Weight | 180.165 | nRig | 13 |
| Exact Molecular Weight | 200.156 | nRing | 3 |
| Solubility: LogS | -5.189 | nHRing | 0 |
| Solubility: LogP | 4.712 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
| Atoms Count | 35 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 38.3859 |
| nHD | 0 | BPOL | 20.0641 |
| QED | 0.516 |
| Synth | 5.956 |
| Natural Product Likeliness | 2.149 |
| NR-PPAR-gamma | 0.006 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.294 |
| Pgp-sub | 0.002 |
| HIA | 0.008 |
| CACO-2 | -4.653 |
| MDCK | 0.0000225 |
| BBB | 0.08 |
| PPB | 0.942646 |
| VDSS | 1.914 |
| FU | 0.0699495 |
| CYP1A2-inh | 0.217 |
| CYP1A2-sub | 0.745 |
| CYP2c19-inh | 0.685 |
| CYP2c19-sub | 0.922 |
| CYP2c9-inh | 0.397 |
| CYP2c9-sub | 0.615 |
| CYP2d6-inh | 0.744 |
| CYP2d6-sub | 0.751 |
| CYP3a4-inh | 0.714 |
| CYP3a4-sub | 0.732 |
| CL | 3.972 |
| T12 | 0.114 |
| hERG | 0.025 |
| Ames | 0.005 |
| ROA | 0.387 |
| SkinSen | 0.037 |
| Carcinogencity | 0.918 |
| EI | 0.709 |
| Respiratory | 0.975 |
| NR-Aromatase | 0.672 |
| Antiviral | Yes |
| Prediction | 0.792099 |